APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 25 filers reported holding APTEVO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,867 | -67.8% | 75,355 | +42.7% | 0.00% | – |
| Q2 2023 | $77,124 | -28.4% | 52,825 | 0.0% | 0.00% | – |
| Q1 2023 | $107,763 | +88230.3% | 52,825 | 0.0% | 0.00% | – |
| Q4 2022 | $122 | -99.9% | 52,825 | -0.3% | 0.00% | – |
| Q3 2022 | $161,000 | -14.8% | 52,961 | 0.0% | 0.00% | – |
| Q2 2022 | $189,000 | -38.8% | 52,961 | +0.4% | 0.00% | – |
| Q1 2022 | $309,000 | -1.3% | 52,727 | +32.5% | 0.00% | – |
| Q4 2021 | $313,000 | -49.2% | 39,807 | -0.3% | 0.00% | – |
| Q3 2021 | $616,000 | -29.4% | 39,924 | +2.6% | 0.00% | – |
| Q2 2021 | $872,000 | -20.1% | 38,917 | +8.8% | 0.00% | – |
| Q1 2021 | $1,091,000 | +5.6% | 35,762 | +26.8% | 0.00% | – |
| Q4 2020 | $1,033,000 | +1175.3% | 28,212 | +163.5% | 0.00% | – |
| Q3 2020 | $81,000 | -9.0% | 10,705 | 0.0% | 0.00% | – |
| Q2 2020 | $89,000 | +134.2% | 10,705 | +3.8% | 0.00% | – |
| Q1 2020 | $38,000 | – | 10,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $64,504,000 | 9.85% |
| Stonepine Capital Management, LLC | 18,280 | $670,000 | 0.51% |
| Ghost Tree Capital, LLC | 50,000 | $1,833,000 | 0.41% |
| Anson Funds Management LP | 45,462 | $1,666,000 | 0.34% |
| RTW INVESTMENTS, LP | 288,236 | $10,564,000 | 0.18% |
| Dynamic Technology Lab Private Ltd | 13,202 | $484,000 | 0.08% |
| Alyeska Investment Group, L.P. | 49,601 | $1,818,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11,493 | $421,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 8,203 | $301,000 | 0.01% |
| Renaissance Technologies | 254,423 | $9,325,000 | 0.01% |